CIK 0001861123 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-07 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-10-02 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-09-08 | 4 | 4 | 2026-09-03 |
| 2026-08-14 | 8-K | 8-K items 7.01,9.01 | 2026-08-13 |
| 2026-08-13 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-13 | 8-K | 8-K items 2.02,9.01 | 2026-08-13 |
| 2026-08-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-03 | 8-K | 8-K items 5.02 | 2026-07-31 |
| 2026-06-15 | 3 | 3 | 2026-06-15 |
| 2026-06-10 | 8-K | 8-K items 5.02 | 2026-06-05 |
| 2026-06-01 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-05-30 |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-13 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-11 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-11 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-05-11 |
| 2026-05-06 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-04-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-03-30 | 8-K | 8-K items 2.02,9.01 | 2026-03-30 |
| 2026-03-30 | 10-K | 10-K | 2025-12-31 |
| 2026-03-04 | 4 | 4 | 2026-03-02 |
| 2026-03-04 | 4 | 4 | 2026-03-02 |
| 2026-03-04 | 4 | 4 | 2026-03-02 |
| 2026-03-04 | 4 | 4 | 2026-03-02 |
| 2026-03-04 | 4 | 4 | 2026-03-02 |
| 2026-03-04 | 4 | 4 | 2026-03-02 |
Forms on file (last 1,000): 3 14, 4 14, 8-K 8, SCHEDULE 13G 6, D 4, SCHEDULE 13G/A 3, DRS/A 3, 10-Q 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=EIKN (0.002 USD), /gw/filings/filings?ticker=EIKN&form=8-K, /gw/filings/facts?ticker=EIKN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange